U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07027202) titled 'Early Preventive Left Ventricle Unloading After VA-ECMO for Refractory Cardiogenic Shock' on May 07.
Brief Summary: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly being used worldwide to treat severe cardiogenic shock. The survival rate of these patients has increased in the last decade, reaching 45-50% for patients with acute myocardial infarction (AMI), the most frequent indication of the technique, 50-60% for patients with end-stage dilated cardiomyopathy bridged to heart transplantation or long-term left ventricle assist device (LVAD) surgery, 60-70% for fulminant myocarditis, while it remains lower f...